Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
High Levels of Phosphatase and Tensin Homolog Expression Are Associated With Tumor Progression, Tumor Recurrence, and Systemic Metastases in pT1 Urothelial Carcinoma of the Bladder: A Tissue Microarray Study of 156 Patients Treated by Transurethral Resection.
Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge.
Autorzy:
Velez Torres JM; From the Department of Pathology and Laboratory Medicine (Velez Torres, Jorda, Kryvenko).; Sylvester Comprehensive Cancer Center (Velez Torres, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida. Gonzalez ML; The Department of Pathology, The University of Alabama at Birmingham, Birmingham (Lora Gonzalez, Zein-Sabatto, Netto). Duarte EM; The Department of Pathology, University of Florida, Gainesville (Martinez Duarte). Zein-Sabatto B; The Department of Pathology, The University of Alabama at Birmingham, Birmingham (Lora Gonzalez, Zein-Sabatto, Netto). Aron M; The Departments of Pathology and Urology, Keck School of Medicine, University of Southern California, Los Angeles (Aron). Gupta NS; The Department of Pathology, Henry Ford Health System, Detroit, Michigan (Gupta). Kerr DA; The Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Kerr).; The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (Kerr). NettoGJ; The Department of Pathology, The University of Alabama at Birmingham, Birmingham (Lora Gonzalez, Zein-Sabatto, Netto). Jorda M; From the Department of Pathology and Laboratory Medicine (Velez Torres, Jorda, Kryvenko).; Desai Sethi Urology Institute (Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.; Sylvester Comprehensive Cancer Center (Velez Torres, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida. Kryvenko ON; From the Department of Pathology and Laboratory Medicine (Velez Torres, Jorda, Kryvenko).; Desai Sethi Urology Institute (Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.; Department of Radiation Oncology (Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.; Sylvester Comprehensive Cancer Center (Velez Torres, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Spindle Cell Sarcoma of the Uterus Harboring MEIS1::NCOA1 Fusion Gene and Mimicking Endometrial Stromal Sarcoma.
Autorzy:
Mejbel HA; Division of Genomics Diagnostics and Bioinformatics, Molecular Genetics Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA. Harada S; Division of Genomics Diagnostics and Bioinformatics, Molecular Genetics Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology, Division of Anatomic Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA. Stevens TM; O'Neal Comprehensive Cancer Center, 189178The University of Alabama at Birmingham, Birmingham, AL, USA. Huang X; O'Neal Comprehensive Cancer Center, 189178The University of Alabama at Birmingham, Birmingham, AL, USA. NettoGJ; Division of Genomics Diagnostics and Bioinformatics, Molecular Genetics Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA.; O'Neal Comprehensive Cancer Center, 189178The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology, Division of Anatomic Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA. Mackinnon AC; Division of Genomics Diagnostics and Bioinformatics, Molecular Genetics Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology, Division of Anatomic Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA. Al Diffalha S; O'Neal Comprehensive Cancer Center, 189178The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology, Division of Anatomic Pathology, 9968The University of Alabama at Birmingham, Birmingham, AL, USA.
Compérat E; Department of Pathology, General Hospital, Medical University Vienna, Vienna, Austria.; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France. Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Knoxville, TN, USA.; Department of Urology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA. Berney DM; Department of Cellular Pathology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Barts Health NHS Trust, London, UK. Cree I; International Agency for Research on Cancer (IARC), World Health Organisation, Lyon, France. Menon S; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich and University Zurich, Zurich, Switzerland. NettoGJ; Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. Rao V; Department of Pathology and Molecular Pathology, University Hospital Zurich and University Zurich, Zurich, Switzerland. Raspollini MR; Histopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Rubin MA; Bern Center for Precision Medicine and Department for Biomedical Research, Bern, Switzerland. Srigley JR; Trillium Health Partners and University of Toronto, Mississauga, ON, Canada. Tan PH; Division of Pathology, Singapore General Hospital, Singapore. Tickoo SK; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London and Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, UK. Tsuzuki T; Department of Surgical Pathology, School of Medicine, Aichi Medical University, Nagoya, Japan.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 439-446. Date of Electronic Publication: 2022 Aug 16.
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Autorzy:
Kench JG; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.; The University of Sydney, Camperdown, New South Wales, Australia. Amin MB; The University of Tennessee Health Science Center, Memphis, TN, USA. Berney DM; Department of Cellular Pathology, Bartshealth NHS Trust, Royal London Hospital, London, UK. Compérat EM; Department of Pathology, University of Vienna, Vienna, Austria. Cree IA; International Agency for Research on Cancer, Lyon, France. Gill AJ; The University of Sydney, Camperdown, New South Wales, Australia.; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales, Australia. Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. Menon S; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. NettoGJ; Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. Raspollini MR; Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy. Rubin MA; Department for BioMedical Research, University of Bern, Bern, Switzerland. Tan PH; Division of Pathology, Singapore General Hospital, Singapore, Singapore. Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan. Turjalic S; Skin and Renal Units, Royal Marsden NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. van der Kwast TH; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Zhou M; Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA. Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 447-458. Date of Electronic Publication: 2022 Aug 02.
An introduction to the WHO 5th edition 2022 classification of testicular tumours.
Autorzy:
Berney DM; Department of Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, QMUL and Barts Health NHS Trust, London, UK. Cree I; WHO Classification of Tumours Group, International Agency for Research on Cancer, World Health Organization, Lyon, France. Rao V; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India. Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich and University Zurich, Zurich, Switzerland. Srigley JR; McMaster University, Hamilton, ON, Canada. Tsuzuki T; Department of Surgical Pathology, Aichi Medical University, School of Medicine, Nagakute, Japan. Amin MB; Department of Pathology and Laboratory Medicine, The University of Tennessee Health Sciences Center, Memphis, TN, USA.; Department of Urology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA. Comperat EM; Department of Pathology, General Hospital, Medical University, Vienna, Austria.; Department of Pathology Tenon Hospital, Sorbonne University, Paris, France. Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University, Erlangen, Germany. Menon S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. NettoGJ; University of Alabama at Birmingham, Pathology, Birmingham, AL, USA. Rubin MA; University of Bern, Director of the Department for BioMedical Research, Bern, Switzerland. Turajlic S; The Francis Crick Institute, London, UK. Raspollini MR; Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy. Tickoo SK; Memorial Sloan-Kettering Cancer Center, Pathology, New York, NY, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 459-466. Date of Electronic Publication: 2022 Jul 01.
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Autorzy:
Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), Porto, Portugal.; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (GEBC CI-IPOP) (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (P.CCC), Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal. Ohashi R; Histopathology Core Facility, Niigata University Faculty of Medicine, Niigata, Japan.; Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, USA.; Department of Urology, University of Southern California, Los Angeles, CA, USA. Berney DM; Centre for Molecular Oncology, Barts and the London School of Medicine and Dentistry, London, UK. Compérat EM; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France. Cree IA; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France. Gill AJ; Sydney Medical School, The University of Sydney, Sydney, Australia.; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, NSW Health Pathology, St Leonards, New South Wales, Australia. Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. Menon S; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. NettoGJ; Department of Pathology, University of Alabama, Birmingham, AL, USA. Raspollini MR; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy. Rubin MA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Department for BioMedical Research, University of Bern, Bern, Switzerland.; Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, NY, USA. Tan PH; Division of Pathology, Singapore General Hospital, Singapore. Tickoo SK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan. Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; The Francis Crick Institute, London, UK. Zhou M; Department of Pathology, Tufts Medical Center, Boston, Massachusetts, USA. Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Moch H; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 426-438. Date of Electronic Publication: 2022 Jun 10.
Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
Autorzy:
Tomiyama E; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Fujita K; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Urology, Kindai University Faculty of Medicine, Sayama, Osaka, Japan. Hashimoto M; Department of Urology, Kindai University Faculty of Medicine, Sayama, Osaka, Japan. Miyamoto H; Departments of, Pathology and Laboratory Medicine.; Urology, University of Rochester Medical Center, Rochester, New York, USA. NettoGJ; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Nonomura N; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer.
Autorzy:
Teramoto Y; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. Jiang G; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, China Medical University, Shenyang 110122, China. Goto T; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. Mizushima T; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Nagata Y; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. NettoGJ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA. Miyamoto H; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Urology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Autorzy:
Hayashi Y; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Fujita K; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan. Banno E; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan. Eich ML; Department of Pathology, University Hospital Cologne, Cologne, Germany. NettoGJ; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Nonomura N; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Autorzy:
Epstein JI; From the Departments of Pathology (Epstein, DeMarzo, Lotan), McGill University Health Center, Montréal, Quebec, Canada.; Urology (Epstein), David Geffen School of Medicine at UCLA, Los Angeles, California (Huang).; and Oncology (Epstein), The Johns Hopkins Medical Institutions, Baltimore, Maryland. Amin MB; Department of Pathology and Laboratory Medicine and Urology, University of Tennessee Health Science, Memphis (Amin). Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Fine). Algaba F; Department of Pathology, Fundacio Puigvert, Barcelona, Spain (Algaba). Aron M; Department of Pathology, University of Southern California, Los Angeles (Aron). Baydar DE; Department of Pathology, Faculty of Medicine, Koç University, İstanbul, Turkey (Baydar). Beltran AL; Department of Pathology, Champalimaud Centre for the Unknown, Lisbon, Portugal (Beltran). Brimo F; Department of Pathology, McGill University Health Center, Montréal, Quebec, Canada (Brimo). Cheville JC; Department of Pathology, Mayo Clinic, Rochester, Minnesota (Cheville, Jimenez). Colecchia M; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (Colecchia). Comperat E; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France (Comperat). da Cunha IW; Pathology Department, Rede D'OR-Sao Luiz, Sao Paulo, SP, Brazil (da Cunha). Delprado W; Douglass Hanly Moir Pathology, Sydney, Australia (Delprado). DeMarzo AM; From the Departments of Pathology (Epstein, DeMarzo, Lotan), McGill University Health Center, Montréal, Quebec, Canada. Giannico GA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Giannico, Gordetsky). Gordetsky JB; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Giannico, Gordetsky). Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Guo). Hansel DE; Department of Pathology, Oregon Health and Science University, Portland (Hansel). Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Hirsch). Huang J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California (Huang). Humphrey PA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Humphrey). Jimenez RE; Department of Pathology, Mayo Clinic, Rochester, Minnesota (Cheville, Jimenez). Khani F; Department of Pathology and Laboratory Medicine and Urology, Weill Cornell Medicine, New York, New York (Khani, Robinson). Kong Q; Department of Pathology, Qingdao Municipal Hospital, Qingdao, Shandong, China (Kong).; Kong is currently located at Kaiser Permanente Sacramento Medical Center, Sacramento, California. Kryvenko ON; Departments of Pathology and Laboratory Medicine and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida (Kryvenko). Kunju LP; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan (Kunju, Mehra). Lal P; Perelman School of Medicine, University of Pennsylvania, Philadelphia (Lal). Latour M; Department of Pathology, CHUM, Université de Montréal, Montréal, Quebec, Canada (Latour). Lotan T; From the Departments of Pathology (Epstein, DeMarzo, Lotan), McGill University Health Center, Montréal, Quebec, Canada. Maclean F; Douglass Hanly Moir Pathology, Faculty of Medicine and Health Sciences Macquarie University, North Ryde, Australia (Maclean). Magi-Galluzzi C; Department of Pathology, The University of Alabama at Birmingham, Birmingham (Magi-Galluzzi, Netto). Mehra R; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan (Kunju, Mehra). Menon S; Department of Surgical Pathology, Tata Memorial Hospital, Parel, Mumbai, India (Menon). Miyamoto H; Departments of Pathology and Laboratory Medicine and Urology, University of Rochester Medical Center, Rochester, New York (Miyamoto). Montironi R; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy (Montironi). NettoGJ; Department of Pathology, The University of Alabama at Birmingham, Birmingham (Magi-Galluzzi, Netto). Nguyen JK; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Nguyen). Osunkoya AO; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia (Osunkoya). Parwani A; Department of Pathology, Ohio State University, Columbus (Parwani, Zynger). Robinson BD; Department of Pathology and Laboratory Medicine and Urology, Weill Cornell Medicine, New York, New York (Khani, Robinson). Rubin MA; Department for BioMedical Research, University of Bern, Bern, Switzerland (Rubin). Shah RB; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas (Shah). So JS; Institute of Pathology, St Luke's Medical Center, Quezon City and Global City, Philippines (So). Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan (Takahashi). Tavora F; Argos Laboratory, Federal University of Ceara, Fortaleza, Brazil (Tavora). Tretiakova MS; Department of Pathology, University of Washington School of Medicine, Seattle (Tretiakova, True). True L; Department of Pathology, University of Washington School of Medicine, Seattle (Tretiakova, True). Wobker SE; Departments of Pathology and Laboratory Medicine and Urology, University of North Carolina, Chapel Hill (Wobker). Yang XJ; Department of Pathology, Northwestern University, Chicago, Illinois (Yang). Zhou M; Department of Pathology, Tufts Medical Center, Boston, Massachusetts (Zhou). Zynger DL; Department of Pathology, Ohio State University, Columbus (Parwani, Zynger). Trpkov K; and Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada (Trpkov).
Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.
Autorzy:
Jiang G; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, China Medical University, Shenyang 110122, Liaoning Province, China. Teramoto Y; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. Goto T; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. Mizushima T; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Inoue S; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Ide H; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Nagata Y; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA. Kashiwagi E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Baras AS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. NettoGJ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA. Yang Z; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. Miyamoto H; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Urology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Feb 26; Vol. 13 (5). Date of Electronic Publication: 2021 Feb 26.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
